Intestinal epithelial secretion regulation

“Intestinal epithelial secretion regulation” describes a physiological process rather than a single molecule, receptor, or canonical therapeutic target. The intestinal epithelium mediates secretion of fluids and electrolytes into the gut lumen, primarily through coordinated activity of multiple ions channels and transporters (including CFTR, NKCC1, NHEs, ENaC, DRA/Slc26a3, and others) arranged in a polarized fashion across apical and basolateral membranes[1][2]. This secretory activity is modulated by diverse signals: immune cell mediators (histamine, prostaglandins, cytokines), neurotransmitters from the enteric nervous system, paracrine factors from stromal cells (like myofibroblasts), and intrinsic pH gradients[1][2]. The regulatory orchestration involves both the mucosal immune system and neural inputs, which act in integrated and dynamic ways to maintain intestinal homeostasis[1][2]. Disruption or over-activation of intestinal epithelial secretion is implicated in conditions such as secretory diarrhea, cystic fibrosis, and certain inflammatory states[1].\n\nThis term does not refer to a single canonical molecule but to a collective physiological process regulated by a broad network of molecular players. Thus, it is not considered a therapeutic \"target\" in the sense of a single receptor or enzyme but rather as an umbrella term for a number of mechanisms and molecules involved in gut secretion and electrolyte transport[1][2].\n\n- The name itself is nonspecific and not suitable for use as a canonical molecular target entry.

Regulation of secretory activity via modulation of epithelial ion channels and transporters by immune mediators, neurotransmitters, and paracrine factors[1][2]\n- Drug targeting of ion transporters such as CFTR, NHEs, and others[2]